新闻中心 - LifeSensors中国区代理商/公司/官网

欢迎来到 LifeSensors中国区代理商/公司/官网

全国咨询热线： 13212737804

LifeSensors中国区代理商/公司/官网

产品中心

推荐产品

invivoCrown IV0120替换BioXCell BE0015-1

invivoCrown IV0112替换BioXCell BE0131

invivoCrown IV0100替换BioXCell BE0146

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：15172431432

传真：18372041646

邮箱：sales@amyjet.com

新闻中心

首页 > 新闻中心

艾美捷科技代理Norgen Biotek品牌。

Norgen Biotek由Yousef Haj-Ahmad博士于1998年创立。Norgen是一家获得ISO 9001、ISO 13485和ISO 15189认证的全面集成生物技术公司，为科学界提供全面的研究服务，如下

一代测序、核酸提取。

Norgen Biotek公司的产品范围包括：RNA、DNA、外切体和蛋白质提取的样品采集，保存，提取和检测相关产品。

（1）样本采集和保存：用于采集和保存各种样本（包括血液、血浆、尿液、粪便、唾液）的设备等等。

（2）纯化和分离：使用 Norgen 易于使用的试剂盒分离和纯化高质量的 RNA、DNA、蛋白质、外泌体等。

（3）NGS 文库制备试剂盒：简单快速的工作流程，用于准备您的下一个小型文库RNA-seq、RNA-seq 和宏基因组学。

（4）分子诊断：使用 Norgen 的 PCR 和 RT-PCR Taqman 检测试剂盒针对多种病原体。还提供其他引物和探针。

（5）实验室组件：酶、缓冲液、试剂、无核酸酶水、塑料和过滤设备。

< " data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Norgen Biotek品牌"> 艾美捷科技代理Norgen Biotek品牌

...

阅读详情

艾美捷科技特约代理Alpco全系列产品

Alpco公司从成立初期就致力于生物医药领域各种免疫检测试剂盒的研发与生产，力求为广大客户提供高质量的免疫检测产品。ALPCO产品种类多样，可测样品来源包括人、大/小鼠、豚鼠、兔、猪、羊、狗、猴等，涉及神经生物学、骨代谢、心血管疾病和氧化应激、细胞因子与信号转导、糖尿病和肥胖症、内分泌学、甲状腺功能、肠胃病学、免疫学、生殖激素、抗体和抗原、分子诊断等多个研究领域，尤以糖尿病和肥胖症研究领域见长。

ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care.

Alpco公司的主要产品包括：

Immunoassays

Flow Cytometry

HPLC/LC-MS

Chemiluminescence

按照研究领域细分

Antibodies & Antigens

Allergy & Infectious Disease

Bone Metabolism

CVD & Oxidative Health

Diabetes & Obesity

Endocrinology

Gastroenterology

Immunology

Neurobiology

Toxicology

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理Alpco全系列产品"> 艾美捷科技特约代理Alpco全系列产品

...

阅读详情

Empire Genomics创立于2006，研究始于纽约布法罗著名的罗斯威尔公园癌症研究所。该实验室在开发高通量技术方面有很强的优势，能够进行全基因组分析，以确定疾病的潜在机制。Empire Genomics在人类基因组计划中发挥了重要作用，创造了作为基因组测序基础的细菌人工染色体，在基因组研究中发挥了重要的专门知识。正是基于这种强大的经验基础，我们才有能力、工具和技术支持研究、临床和药物发现。

Empire Genomics is a clinical molecular diagnostics company. We offer a comprehensive menu of products and services that are used in guiding precise treatments for patients. We work with our clinical, research and biopharmaceutical clients to create innovative and custom solutions to make personalized medicine a reality.

Empire Genomics公司的主要产品包括：

ID Labs Products

FISH Probes

BAC Clones

Genotyping

Circulating Tumor Cells

Gene Expression Services

Custom Services

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Empire Genomics"> Empire Genomics

...

阅读详情

艾美捷科技特约代理美国Fitzgerald公司产品。

美国Fitzgerald Industries International, Inc.(简称FII公司)，专门供应研究和生产体外诊断试剂用原料，产品超过9000多种，主要产品有：

（1）免疫比浊法用特种蛋白抗体：ApoAI, ApoB, IgG, IgA, IgM, C3, C4, TRF, CRP, Lp(a), PA, Albumin, β2-Microglobulin, etc;

（2）化学发光免疫测定法（CLIA）、酶联免疫测定法（EIA）、放射免疫测定法（RIA）、荧光免疫法（FIA）测定用各类高纯单克隆、多克隆抗体，纯化抗原；

（3）癌症系列抗原和抗体，如CA50, CEA, CA, AFP, CA 125, CA15-3, CA19-9, CA72-4, etc；

（4）配对抗体和抗原，如性腺，甲状腺系列等。

Fitzgerald is a manufacturer and supplier of primary antibodies, secondary antibodies, recombinant and native proteins, ELISA kits, Serum and Plasma, and many other biological reagents. Our motto ‘Bringing Life to Science’ illustrates our personal approach to addressing the individual needs, interests and expertise of our customers. We believe that our outstanding customer service and excellent quality products at competitive prices are key to our success.

Fitzgerald的主要产品类型包括：

（1）PRIMARY ANTIBODIES

Monoclonal Antibodies (8795)

Conjugated Monoclonal Antibodies (1329)

Purified Polyclonal Antibodies (28322)

Polyclonal Antibodies (3331)

Conjugated Polyclonal Antibodies (1551)

Antibody Matched Pairs (516)

（2）SECONDARY ANTIBODIES

Unconjugated Secondary Antibodies (179)

Purified Secondary Antibodies (235)

Conjugated Secondary Antibodies (1209)

（3）PROTEINS

Recombinant Proteins (2179)

Conjugated Proteins (3031)

Hapten Conjugates (474)

Complements (22)

Blocking Peptides (10052)

Native Proteins (773)

（4）IMMUNOGLOBULINS

Purified Immunoglobulins (171)

Conjugated Immunoglobulins (114)

（5）BIOLOGICAL REAGENTS

Poly-HRP Products (53)

Enzymes (106)

Colloidal Gold & Silver Products (37)

Diluents (40)

Chemical Reference (123)

Surfactants (4)

Substrates (12)

IHC Reagents (54)

Mounting Media & Preservatives (5)

Controls & Calibrators (50)

Isotype Controls (61)

（6）RESEARCH KITS

（7）SERUM, PLASMA & BLOOD

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Fitzgerald"> Fitzgerald

...

阅读详情

Matreya公司专注于脂类生物化学，公司能够为全世界的客户提供一整套完整的脂类生物化学产品线，包括：鞘脂、糖脂、神经节苷脂、球三糖神经酰胺、脂肪酸和甾醇类。Matreya公司以高纯度的产品，赢得了客户的广泛赞誉。

Matreya LLC is a lipid biochemical company offering a comprehensive line of sphingolipids, glycosphingolipids, gangliosides, globotriaosylceramides, phospholipids, fatty acids, and sterols. We have a trusted and established reputation for high purity products and dedicated technical assistance. Our pride and reputation is in our customer satisfaction.

Matreya公司的主要产品包括：

Antibodies for Glycolipids

Bacterial Tetraethers

Biotinylated Standards

Ceramides and Dihydroceramides

Cholestane Derivatives

Enzyme Inhibitors for Glycolipids

Fatty Acids and Methyl Esters

Fluorescent Standards

Gangliosides

Glycosphingolipids

Glycosyl Glycerides

Lipid Mixtures

Plant Sterols and Steryl Glucosides

Phosphatidylinositol Phosphates

Phospholipids

Phosphosphingolipids

Sphingosines

Stable Isotope Labeled Standards

Tocopherols and Tocotrienols (Vitamin E)

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Matreya"> Matreya

...

阅读详情

艾美捷科技代理Berry & Associates全系列修饰核苷酸等

美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。

Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.

Berry & Associates的主要产品包括：

产品名称	产品编号	纯度	规格
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2'-3'-Dideoxyguanosine	PR 3505	≥95%	25 mg; 100 mg
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
2',3'-Dideoxyuridine	PY 7278	≥97%	100 mg; 500 mg
2',3'-Didehydro-2',3'-dideoxyuridine	PY 7279	≥97%	25 mg; 100 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
2-Amino-2'-deoxyadenosine	PR 3060	≥97%	1 g; 5 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine	PR 3080	≥95%	100 mg; 1 g
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-isobutyryl-2'-deoxyadenosine	PR 3130	≥95%	100 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3670	≥95%	100 mg; 1 g
2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine	PR 3070	≥97%	25 mg; 100 mg
2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine	PR 3160	≥97%	100 mg; 250 mg
2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate	PR 3180	≥97%	25 mg; 100 mg
2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine	PR 3680	≥97%	100 mg; 1 g
6-N-Acyl-6-N-methyl-2'-deoxyadenosine	PR 3006	≥95%	25 mg; 100 mg
8-Amino-2'-deoxyadenosine	PR 3115	≥97%	10 mg; 100 mg
N6-(6-Aminohexyl)-2'-deoxyadenosine	PR 3120	≥90%	100 mg; 1 g
8-Azido-2'-deoxyadenosine	PR 3125	≥97%	10 mg; 100 mg
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine	PR 3230	≥95%	50 mg; 250 mg
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine	PR 3260	≥95%	100 mg; 1 g
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
8-Benzyloxy-2'-deoxyadenosine	PR 3280	≥97%	100 mg; 1 g
8-Bromo-2'-deoxyadenosine	PR 3290	≥90%	2 g; 10 g
8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3320	≥95%	100 mg; 1 g
8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine	PR 3340	≥97%	0g (discontinued);
2'-Deoxyadenosine Monohydrate	PR 3445	≥97%	25 g; 100 g
2',3'-Dideoxyadenosine	PR 3495	≥95%	25 mg; 100 mg
2-Fluoro-2'-deoxyadenosine	PR 3496	≥97%	25 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
N6-Methyl-2'-deoxyadenosine	PR 3740	≥97%	100 mg; 1 g
4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine	PRA 10012	≥95%	10 mg; 50 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine	PRA 10032	≥95%	10 mg; 50 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
8-Allyloxy-2'-deoxyguanosine	PR 3010	≥90%	0Discontinued;
8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3015	≥90%	1 g; 10 g
8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3020	≥90%	1 g; 10 g
5'-Azido-5'-deoxyguanosine	PR 3225	≥90%	5 mg; 10 mg
8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine	PR 3285	≥90%	1 g; 10 g
8-Bromo-2'-deoxyguanosine	PR 3300	≥90%	1 g; 5 g
8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine	PR 3310	≥97%	500 mg; 1 g
8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine	PR 3330	≥90%	250 mg; 1 g
5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine	PR 3335	≥95%	100 mg; 1 g
2'-Deoxyguanosine monohydrate	PR 3452	≥97%	10 g; 100 g
α-2'-Deoxyguanosine	PR 3455	≥97%	10 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine	PR 3600	≥97%	100 mg; 1 g
3',5'-Di-O-acetyl-2'-deoxyguanosine	PR 3605	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine	PR 3630	≥97%	100 mg; 1 g
N2-Ethyl-2'-deoxyguanosine	PR 3700	≥95%	25 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
N2-Isobutyl-2'-deoxyguanosine	PR 3745	≥97%	10 mg; 100 mg
N1-Methyl-2'-deoxyguanosine	PR 3748	≥97%	25 mg; 1 g
N2-Methyl-2'-deoxyguanosine	PR 3750	≥97%	25 mg; 100 mg
O6-Methyl-2'-deoxyguanosine	PR 3755	≥90%	5 mg; 25 mg
6-Thio-2'-deoxyguanosine	PR 3845	≥97%	10 mg; 100 mg
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3090	≥97%	250 mg; 1 g
2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine	PR 3110	≥95%	250 mg; 1 g
2-Amino-N2-O-methyladenosine	PR 3150	≥97%	1 g; 10 g
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
2'-O-Methyladenosine	PR 3734	≥97%	1 g;
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-2'-O-methyl-4-thiouridine	PY 7575	≥97%	10 mg; 100 mg
5-Fluoro-2'-O-methyl-4-(methylithio)uridine	PY 7577	≥97%	10 mg; 100 mg
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine	PR 3000	≥97%	25 mg; 250 mg
3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine	PR 3200	≥90%	50 mg; 250 mg
3'-Azido-2',3'-dideoxyadenosine	PR 3210	≥97%	10 mg; 25 mg
3'-Azido-2',3'-dideoxyguanosine	PR 3220	≥97%	10 mg; 25 mg
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
N6-Benzoyl-3'-deoxyadenosine	PR 3240	≥97%	100 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine	PR 3250	≥97%	100 mg; 1 g
3'-Deoxyadenosine	PR 3430	≥97%	10 mg; 100 mg
3'-Deoxyguanosine	PR 3460	≥97%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine	PR 3590	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-3'-deoxyguanosine	PR 3690	≥97%	20 mg; 100 mg
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine	PY 7230	≥97%	100 mg;
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3040	≥97%	1 g;
2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3045	≥95%	1 g;
2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine	PR 3050	≥95%	5 g; 25 g
6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine	PR 3370	≥97%	100 mg; 1 g
6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine	PR 3380	≥90%	100 mg; 1 g
6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine	PR 3390	≥97%	0 g;
6-Chloro-9-(β-D-ribofuranosyl)purine	PR 3400	≥97%	5 g; 10 g
Adenosine	PR 3005	≥97%	100 g; 1 kg
8-Methyladenosine	PR 3007	≥95%	25 mg; 100 mg
Vidarabine	PR 3008	≥97%	1 g; 5 g
2-Aminoadenosine (2,6-Diaminopurine riboside)	PR 3030	≥97%	2 g; 10 g
N1-Methyladenosine hydroiodide	PR 3032	≥95%	100 mg; 1 g
2-Methyladenosine	PR 3035	≥97%	10 mg; 25 mg
5'-Chloro-5'-deoxyadenosine	PR 3360	≥97%	100 mg; 1 g
N6-Methyladenosine	PR 3732	≥97%	100 mg; 1 g
N6-Methyl-2'-O-Methyladenosine	PR 3733	≥97%	50 mg; 100 mg
3-Deaza-3-methyl-2'-deoxyadenosine	PRA 10013	≥97%	10 mg; 25 mg
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10000	≥97%	100 mg; 1 g
2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine	PRA 10005	≥97%	500 mg; 1 g
4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine	PRA 10006	≥90%	25 mg; 100 mg
8-Azaadenosine	PRA 10007	≥97%	20 mg;
8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine)	PRA 10008	≥95%	10 mg; 100 mg
4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine	PRA 10009	≥95%	100 mg; 1 g
N6-Benzoyl-7-deaza-2'-deoxyadenosine	PRA 10010	≥97%	100 mg; 1 g
Allopurinol riboside	PRA 10011	≥97%	25 mg; 1 g
5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine	PRA 10019	≥97%	500 mg; 1 g
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine	PRA 10020	≥97%	100 mg; 1 g
3-Deaza-2'-deoxyadenosine	PRA 10025	≥97%	25 mg; 100 mg
7-Deaza-2'-deoxyadenosine	PRA 10030	≥97%	100 mg; 1 g
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg; 100 mg
5-Iodo-2'-deoxytubercidin	PRA 10036	≥95%	10 mg; 50 mg
7-Deaza-2'-deoxyguanosine	PRA 10040	≥97%	100 mg; 1 g
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
7-Deaza-2'-deoxyxanthosine	PRA 10050	≥97%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine	PRA 10055	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
5-Iodotubercidin	PRA 10095	≥90%	5 mg; 25 mg
5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10100	≥97%	100 mg; 1 g
N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine	PRA 10110	≥97%	100 mg; 1 g
Sangivamycin	PRA 10140	≥97%	10 mg; 25 mg
Toyocamycin	PRA 10150	≥97%	10 mg; 100 mg
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
dNaM	FC 8110	≥97%	25 mg; 100 mg
9-Deaza-2'-deoxyguanosine	PRA 10120	≥97%	10 mg; 100 mg
9-Deazaguanosine	PRA 10130	≥97%	10 mg; 100 mg
2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine	PYA 11000	≥97%	10 mg; 25 mg
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
2'-Deoxypseudoisocytidine	PYA 11005	≥97%	10 mg; 100 mg
2'-Deoxypseudouridine	PYA 11010	Purity: ≥97%	25 mg;
5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine	PYA 11035	Purity: ≥97%	50 mg; 100 mg
1,3-Dimethyl-2'-deoxypseudouridine	PYA 11040	≥97%	10 mg; 100 mg
1,3-Dimethylpseudouridine	PYA 11050	≥97%	10 mg; 50 mg
N1-Methylpseudouridine	PYA 11052	≥95%	10 mg; 50 mg
N3-Methylpseudouridine	PYA 11054	≥97%	10 mg; 25 mg
Showdomycin	PYA 11056	≥97%	10 mg;
Pseudoisocytidine hydrochloride	PYA 11060	≥97%	10 mg; 100 mg
Pseudothymidine	PYA 11070	≥97%	10 mg; 100 mg
Pseudouridine	PYA 11080	≥97%	10 mg; 50 mg
3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine	PR 3350	≥97%	10 mg;
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-Deoxy-8,5'-cycloadenosine	PR 3440	≥97%	10 mg; 100 mg
2',5'-Dideoxy-8,5'-cycloadenosine	PR 3500	≥97%	10 mg;
2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine	PR 3730	≥97%	10 mg; 100 mg
5'-Oxo-8,5'-cycloadenosine	PR 3800	≥97%	10 mg; 100 mg
5'-Oxo-2'-deoxy-8,5'-cycloadenosine	PR 3810	≥97%	10 mg;
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7010	≥95%	0 g DISCONTINUED;
N4-Acetyl-5'-methyl-2'-O-methylcytidine	PY 7020	≥97%	0 g DISCONTINUED;
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine	PY 7054	≥97%	25 mg; 100 mg
N4-Benzoyl-3'-deoxycytidine	PY 7080	≥97%	20 mg; 100 mg
N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine	PY 7100	≥95%	100 mg; 1 g
N4-Benzoyl-2'-O-methylcytidine	PY 7110	≥97%	500 mg; 1 g
5-Bromo-2'-deoxycytidine	PY 7115	≥97%	1 g; 10 g
Cytidine	PY 7215	≥97%	50 g; 500 g
2'-Deoxycytidine	PY 7216	≥97%	10 g; 50 g
2'-Deoxycytidine Hydrochloride	PY 7217	≥97%	5 g; 50 g
5'-Azido-2',5'-dideoxycytidine	PY 7219	≥97%	25 mg; 100 mg
3'-Deoxycytidine	PY 7220	≥97%	20 mg; 100 mg
N4-Ethyl-2'-deoxycytidine	PY 7245	≥97%	100 mg; 250 mg
5-Methyl-2'-deoxyisocytidine	PY 7255	≥95%	500 mg; 1 g
6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7270	≥97%	20 mg; 50 mg
2',3'-Dideoxycytidine	PY 7325	≥95%	50 mg; 100 mg
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine	PY 7350	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine	PY 7360	≥97%	0 DISCONTINUED;
N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine	PY 7370	≥97%	0 DISCONTINUED;
6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one	PY 7380	≥97%	50 mg;
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine	PY 7400	≥97%	100 mg; 500 mg
5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine	PY 7410	≥97%	100 mg;
6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one	PY 7540	≥95%	250 mg; 500 mg
Cytidin-5-yl-methanesulfonate sodium salt hydrate	PY 7586	≥95%	50 mg; 100 mg
5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine	PY 7587	≥97%	10 mg; 50 mg
5-Hydroxymethyl-2'-deoxycytidine	PY 7588	≥97%	50 mg; 100 mg
5-Formyl-2'-deoxycytidine	PY 7589	≥97%	5 mg; 10 mg
5-Carboethoxy-2'-deoxycytidine	PY 7592	≥95%	25 mg; 100 mg
2'-Deoxycytidine-5-carboxylic acid, sodium salt	PY 7593	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxymethylcytidine	PY 7596	≥97%	50 mg; 100 mg
Cytidine-5-carboxylic acid, sodium salt	PY 7598	≥97%	10 mg; 50 mg
5-Formylcytidine	PY 7599	≥97%	5 mg; 10 mg
5-Iodo-2'-deoxycytidine	PY 7607	≥97%	2 g; 10 g
5-Iodocytidine	PY 7609	≥97%	5 g;
5-Iodo-2'-O-methylcytidine	PY 7620	≥90%	20 mg; 100 mg
5-Methyl-2'-deoxycytidine Hydrochloride	PY 7635	≥97%	0.25 g; 1 g
2'-O-Methylcytidine	PY 7636	≥97%	1 g; 5 g
5-Methylcytidine	PY 7637	≥97%	1 g; 5 g
N4-Methylcytidine	PY 7638	≥97%	25 mg; 100 mg
5-Methyl-2'-O-methylcytidine	PY 7640	≥97%	100 mg; 500 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
5-(1-Propynyl)-2'-O-methylcytidine	PY 7660	≥95%	10 mg; 50 mg
5-(1-Propynyl)-2'-deoxycytidine	PY 7700	≥90%	5 mg; 10 mg
2-Thiocytidine	PY 7721	≥97%	10 mg; 100 mg
2-Thio-2'-deoxycytidine	PY 7723	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
N6-Benzoyl-8-oxo-2'-deoxyadenosine	PR 3270	≥97%	100 mg; 1 g
(5'S)-8,5'-Cycloadenosine	PR 3410	≥97%	10 mg; 100 mg
(5'S)-2'-Deoxy-8,5'-cycloadenosine	PR 3420	≥97%	10 mg;
5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3610	≥97%	100 mg; 1 g
8-Oxo-2'-deoxyadenosine	PR 3705	≥95%	25 mg; 250 mg
8-Oxo-2'-deoxyguanosine	PR 3710	≥97%	25 mg; 250 mg
8-Oxo-N2-isobutyryl-2'-deoxyguanosine	PR 3720	≥90%	100 mg; 1 g
8-Hydroxyguanosine	PR 3795	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
5-Aza-2'-deoxycytidine	PY 7105	≥95%	25 mg; 100 mg
5,6-Dihydro-5-aza-2'-deoxycytidine	PY 7106	≥97%	25 mg; 100 mg
5,6-Dihydro-2'-deoxyuridine	PY 7330	≥97%	100 mg;
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
5-Hydroxy-2'-deoxycytidine	PY 7595	≥95%	25 mg; 250 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
6-Methylcytidine	PY 7641	≥97%	10 mg; 25 mg
Nap-dU	PY 7735	≥97%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
3,N4-Etheno-2'-deoxycytidine	PYA 11130	≥97%	100 mg; 500 mg
Pyrrolo-dC	PYA 11090	≥95%	10 mg; 100 mg
6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one	PYA 11092	≥97%	10 mg; 100 mg
3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one	PYA 11095	≥95%	100 mg; 1 g
3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione	PYA 11100	≥95%	10 mg; 100 mg
8-18O-Hydroxyguanosine	IOPR 3795	≥95%	2 mg; 5 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine	PR 3701	≥95%	25 mg; 100 mg
N2-Dimethylguanosine	PR 3702	≥97%	10 mg; 100 mg
Guanosine	PR 3703	≥97%	100 g; 500 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
O6-Methylguanosine	PR 3757	≥97%	25 mg; 100 mg
2'-O-Methylguanosine	PR 3760	≥97%	1 g; 10 g
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
8-Bromoguanosine	PR 3796	≥97%	0 g;
8-Benzyloxyguanosine	PR 3797	≥95%	100 mg; 1 g
7-Methyl-7-deaza-2'deoxyguanosine	PRA 10042	≥97%	10 mg; 50 mg
7-Deazaguanosine	PRA 10045	≥97%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
2'-Deoxypseudoguanosine	PRA 10103	≥97%	10 mg; 50 mg
2'-Deoxypseudoisoguanosine	PRA 10104	≥97%	10 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole	PRA 10060	≥97%	100 mg; 1 g
1-(β-D-2-Deoxyribofuranosyl)-4-methylindole	PRA 10070	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole	PRA 10080	≥97%	0 g;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole	PRA 10090	≥97%	100 mg; 1 g
2'-Deoxy-4-desmethylwyosine	PR 3450	≥95%	100 mg; 500 mg
2'-Deoxyinosine	PR 3463	≥97%	10 g; 100 g
5'-Azido-2',5'-dideoxyinosine	PR 3464	≥97%	5 mg; 25 mg
3',5'-Di-O-acetyl-2'-deoxyinosine	PR 3480	≥97%	1 g;
3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine	PR 3490	≥90%	1 g;
5'-O-(Dimethoxytrityl)-2'-O-methylinosine	PR 3640	≥97%	1 g;
5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine	PR 3660	≥97%	100 mg; 1 g
Inosine	PR 3725	≥97%	100 g; 500 g
2',3'-Dideoxyinosine	PR 3727	≥97%	100 mg; 1 g
2'-O-Methylinosine	PR 3770	≥97%	500 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
O6-Phenyl-2'-deoxyinosine	PR 3840	≥97%	100 mg; 1 g
2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3842	≥97%	25 mg;
5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine	PR 3843	≥90%	25 mg; 100 mg
2'-Deoxyisoguanosine	PR 3465	≥97%	10 mg; 100 mg
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine	PR 3510	≥90%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3520	≥95%	100 mg; 1 g
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine	PR 3530	≥90%	100 mg; 1 g
Isoguanosine	PR 3735	≥97%	10 mg; 50 mg
d5SICS	FC 8120	≥97%	25 mg; 100 mg
AICA Riboside (AICAR)	MN 20001	≥97%	0 g (DISCONTINUED);
2',3'-Di-O-methyladenosine	PR 3540	≥97%	100 mg; 1 g
2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine	PR 3692	≥95%	10 mg; 100 mg
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg; 100 mg
8-Aza-7-deaza-2'-deoxyguanosine	PRA 10170	≥95%	10 mg; 100 mg
6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one	PRA 10175	≥95%	10 mg; 100 mg
3'-Deoxy-3',4'-didehydrocytidine	PY 7790	≥95%	10 mg; 25 mg
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
tC Nucleoside	PYA 11110	≥97%	50 mg; 100 mg
tCnitro Nucleoside	PYA 11115	≥95%	5 mg; 25 mg
2'-Deoxynebularine	PR 3470	Purity: ≥97%	100 mg; 1 g
7-Methylinosine	PR 3780	≥95%	100 mg; 250 mg
7-Methyl-6-thioguanosine	PR 3790	≥75%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole	PYA 11020	≥97%	50 mg;
1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole	PYA 11030	≥95%	100 mg;
Showdomycin	PYA 11056	≥97%	10 mg;
Formycin A	PYA 11001	≥97%	10 mg;
Formycin B	PYA 11002	≥97%	10 mg;
Pseudouridine	PYA 11080	≥97%	10 mg;
Pyrazofurin	PYA 11004	≥97%	10 mg;
Toyocamycin	PRA 10150	≥97%	10 mg;
7-Deazaadenosine (tubercidin)	PRA 10035	≥97%	10 mg;
Allopurinol riboside	PRA 10011	≥97%	25 mg;
5-Iodotubercidin	PRA 10095	≥90%	5 mg;
Triciribine	PRA 10160	≥97%	10 mg;
Tricyclic Nucleoside Phosphate	PRA 10162	≥95%	10 mg;
5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione	PRA 10047	≥97%	10 mg;
5'-Amino-5'-deoxythymidine	PY 7030	≥97%	25 mg; 50 mg
O2,5'-Anhydrothymidine	PY 7060	≥95%	500 mg; 1 g
3'-Azido-3'-deoxythymidine (AZT)	PY 7065	≥97%	500 mg; 1 g
5'-Azido-5'-deoxythymidine	PY 7070	≥97%	25 mg; 100 mg
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7120	≥97%	1 g;
3'-O-(t-Butyldimethylsilyl)thymidine	PY 7130	≥95%	500 mg; 1 g
5'-O-(t-Butyldimethylsilyl)thymidine	PY 7140	≥97%	5 g; 10 g
3',5'-bis-O-(t-Butyldimethylsilyl)thymidine	PY 7150	≥97%	1 g; 5 g
3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine	PY 7160	≥95%	100 mg; 500 mg
S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine	PY 7200	≥95%	10 mg; 100 mg
S4-(2-Cyanoethyl)-4-thiothymidine	PY 7210	≥95%	10 mg; 100 mg
5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine	PY 7250	≥97%	1 g;
3'-Deoxythymidine	PY 7277	≥95%	50 mg; 100 mg
1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one	PY 7315	≥90%	1 g; 10 g
2',3'-Didehydro-3'-deoxythymidine	PY 7328	≥95%	10 mg; 100 mg
(5S)-5,6-Dihydrothymidine	PY 7340	≥97%	20 mg; 100 mg
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
(5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine	PY 7390	≥97%	100 mg;
5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine	PY 7510	≥97%	50 mg; 100 mg
2-O-Ethylthymidine	PY 7561	≥97%	500 mg; 1 g
5'-Iodo-5'-deoxythymidine	PY 7610	≥97%	250 mg; 1 g
5'-O-Methylthymidine	PY 7680	≥95%	50 mg; 100 mg
2-Thiothymidine	PY 7725	≥95%	20 mg; 100 mg
Thymidine	PY 7727	≥97%	25 g; 250 g
5'-O-(p-Toluenesulfonyl)thymidine	PY 7740	≥97%	5 g;
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5'-Trifluoroacetamido-5'-deoxythymidine	PY 7750	≥97%	50 mg;
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
6-Azathymidine	PYA 11058	≥95%	25 mg; 100 mg
NPOM-Caged-dT CEP	BA 0317	≥95%	100 µmol; 0.25 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
3'-Azido-3'-deoxy-5'-O-methylthymidine	PY 7075	≥97%	0 g DISCONTINUED;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
(5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine	PY 7345	≥95%	10 mg; 25 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
3-(2-Cyanoethyl)thymidine	PY 7742	≥95%	10 mg; 25 mg
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
NPOM-Caged deoxythymidine	PY 7795	≥97%	25 mg; 100 mg
6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one	PYA 11055	≥97%	5 mg; 25 mg
5-Ethynyl uridine CEP	BA 0353	≥90%	100 µmol; 0.25 g
2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine	PY 7000	≥97%	500 mg; 1 g
5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7040	≥97%	100 mg; 1 g
5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine	PY 7050	≥90%	100 mg; 1 g
5-(Furan-2-yl)-2'-deoxyuridine	PY 7053	≥97%	25 mg; 100 mg
1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one	PY 7055	≥97%	20 mg; 100 mg
5-Bromo-2'-deoxyuridine	PY 7117	≥97%	10 g; 25 g
5-Bromouridine	PY 7118	≥95%	5 g;
(E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine	PY 7170	≥97%	1 g;
(E)-5-(2-Carbomethoxyvinyl)uridine	PY 7172	≥97%	25 mg; 250 mg
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine	PY 7180	≥97%	500 mg; 1 g
(E)-5-(2-Carboxyvinyl)uridine	PY 7185	≥97%	1 g;
(E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester	PY 7190	≥97%	100 mg; 1 g
S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine	PY 7212	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine	PY 7240	≥95%	25 mg; 100 mg
5-Methyl-3'-deoxyuridine	PY 7260	≥95%	20 mg; 50 mg
2'-Deoxyuridine	PY 7275	≥97%	25 g; 100 g
3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine	PY 7280	≥95%	100 mg; 500 mg
3'-Azido-2',3'-dideoxy-5-bromouridine	PY 7286	≥97%	10 mg; 50 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7290	≥95%	500 mg; 1 g
3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine	PY 7300	≥97%	50 mg; 250 mg
3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7310	≥97%	20 mg; 50 mg
3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine	PY 7320	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine	PY 7420	≥95%	100 mg; 500 mg
5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine	PY 7450	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine	PY 7460	≥97%	50 mg; 100 mg
5-Methoxymethyl-2'-deoxyuridine	PY 7465	≥95%	10 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine	PY 7470	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-2'-O-methyluridine	PY 7480	≥97%	500 mg; 1 g
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine	PY 7490	≥95%	50 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine	PY 7500	≥95%	25 mg; 100 mg
5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine	PY 7520	≥97%	100 mg; 1 g
5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7530	≥97%	100 mg; 1 g
1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one	PY 7550	≥95%	100 mg; 1 g
3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine	PY 7560	≥95%	500 mg; 1 g
5-Ethynyl-2'-deoxyuridine	PY 7562	≥97%	25 mg; 100 mg
5-Ethynyl uridine	PY 7563	≥97%	10 mg; 100 mg
5-Fluoro-2'-deoxyuridine	PY 7565	≥97%	100 mg; 1 g
5-Fluoro-2'-O-methyluridine	PY 7570	≥97%	50 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine	PY 7580	≥97%	25 mg; 100 mg
5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine	PY 7590	≥95%	25 mg; 100 mg
5-Hydroxy-2'-deoxyuridine	PY 7597	≥95%	25 mg; 250 mg
5-(2-Hydroxyethyl)-2'-deoxyuridine	PY 7600	≥95%	25 mg; 50 mg
5-Acetoxymethyl-2'-deoxyuridine	PY 7604	≥97%	25 mg; 100 mg
5-Hydroxymethyl-2'-deoxyuridine	PY 7605	≥95%	25 mg; 250 mg
2'-Fluoro-5'-iodo deoxyuridine	PY 7612	≥95%	100 mg;
5-Iodo-2'-deoxyuridine	PY 7615	≥97%	10 g; 25 g
5-Iodo-2'-O-methyluridine	PY 7630	≥97%	100 mg; 1 g
5-Iodouridine	PY 7632	≥95%	5 g; 25 g
5-Methyl-2'-O-methyluridine	PY 7650	≥97%	100 mg; 1 g
5-(1-Propynyl)-2'-O-methyluridine	PY 7670	≥97%	10 mg; 25 mg
2'-O-Methyluridine	PY 7690	≥97%	5 g;
3-Methyluridine	PY 7694	≥97%	25 mg; 100 mg
5-Methyluridine	PY 7695	≥97%	200 mg; 1 g
5-(1-Propynyl)-2'-deoxyuridine	PY 7710	≥97%	100 mg; 1 g
5-(Propargyloxy)-2'-deoxyuridine	PY 7712	≥95%	10 mg; 100 mg
Zebularine	PY 7715	≥97%	10 mg; 25 mg
3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine	PY 7720	≥90%	500 mg; 1 g
2-Thiouridine	PY 7724	≥97%	25 mg; 100 mg
5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine	PY 7730	≥97%	1 g; 5 g
5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine	PY 7754	≥95%	100 mg; 1 g
5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine	PY 7758	≥97%	100 mg; 1 g
5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7760	≥90%	100 mg; 1 g
5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine	PY 7770	≥95%	100 mg; 1 g
5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine	PY 7775	≥97%	100 mg; 1 g
Uridine	PY 7780	≥97%	100 g; 500 g
2'3'-O-Isopropylidene uridine	PY 7781	≥97%	5 g; 25 g
5-Hydroxymethyl uridine	PY 7782	≥97%	50 mg; 100 mg
5-Methoxyuridine	PY 7783	≥97%	10 mg; 50 mg
6-Aza-2'-deoxyuridine	PYA 11057	≥95%	50 mg; 100 mg

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸

...

阅读详情

艾美捷科技代理Sterlitech全系列产品。

主要产品包括：（1）过滤器：滤膜、注射器过滤器和胶囊过滤器；（2）过滤器支架：各种过滤器支架配置；（3）膜/工艺开发：聚合物平板膜、陶瓷膜，台架横向/切向流动试验室和过滤设备；（4）实验室设备：真空泵、流体输送/储存系统、加热板/搅拌器等。

点击并打开产品列表

http://www.amyjet.com/Index/lists/catid/27/kid/70.html

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Sterlitech全系列滤膜、滤器"> 艾美捷科技代理Sterlitech全系列滤膜、滤器

...

阅读详情

Neuromab是一家由NIH资助成立的单克隆抗体库。

The UC Davis/NIH NeuroMab Facility is a national monoclonal antibody-generating resource funded by the National Institutes of Health (NIH). The mission of the UC Davis/NIH NeuroMab Facility is to provide a unique neuroscience-based approach to generating mouse monoclonal antibodies optimized for use in mammalian brain (NeuroMabs). NeuroMabs are generated from mice immunized with synthetic and recombinant immunogens corresponding to components of the neuronal proteome as predicted from genomic and other large-scale cloning efforts. Comprehensive biochemical and immunohistochemical analyses of human, primate and non-primate mammalian brain are incorporated into the UC Davis/NIH NeuroMab Facility screening procedure. This yields a subset of mouse mAbs that are optimized for use in brain (i.e., NeuroMabs): for immunohistochemical- based imaging studies of protein localization in adult, developing and pathological brain samples, for biochemical analyses of subunit composition and post-translational modifications of native brain proteins, and for proteomic analyses of native brain protein networks.

Neuromab的主要产品包括：

Array Tomography

Model Organisms

Disease Targets

产品列表：

抗体名称

Anti-5-formylcytidine, NeuroMab clone N358/68

Anti-5-hydroxymethylcytidine, NeuroMab clone N297/59

Anti-6xHis, NeuroMab clone N144/14

Anti-ADAM11, NeuroMab clone N441/35

Anti-ADAM22-cytoplasmic, NeuroMab clone N46/30

Anti-ADAM22-extracellular, NeuroMab clone N57/2

Anti-AGPS neo-epitope, NeuroMab clone N444/63

Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/39

Anti-Aldh1L1 (Aldehyde dehydrogenase family 1 member L1), NeuroMab clone N103/31

Anti-Alg13, NeuroMab clone N442/28

Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/80

Anti-Alpha-2C adrenergic receptor, NeuroMab clone N330A/51

Anti-AMIGO-1, NeuroMab clone L86/33

Anti-AMIGO-1, NeuroMab clone L86/36

Anti-AMIGO-1, NeuroMab clone L86A/37

Anti-Ankyrin-B, NeuroMab clone N105/13

Anti-Ankyrin-B, NeuroMab clone N105/17

Anti-Ankyrin-G, NeuroMab clone N106/20

Anti-Ankyrin-G, NeuroMab clone N106/36

Anti-Ankyrin-G, NeuroMab clone N106/65

Anti-Ankyrin-G, NeuroMab clone N106/43

Anti-Ankyrin-R, NeuroMab clone N388A/10

Anti-Ankyrin-R/G, NeuroMab clone N388A/27

Anti-ANO3/TMEM16C, NeuroMab clone N454/91

Anti-ANO5/TMEM16E, NeuroMab clone N421A/85

Anti-ANO6/TMEM16F, NeuroMab clone N429/19

Anti-ARHGAP4, NeuroMab clone N290B/25

Anti-Arl13b, NeuroMab clone N295B/66

Anti-Arx, NeuroMab clone N411/51

Anti-ASIC1, NeuroMab clone N271/44

Anti-ATAT1, NeuroMab clone N347/42

Anti-Ataxin-1 11NQ, NeuroMab clone N76/8

Anti-Ataxin-1 11NQ, NeuroMab clone N76/3

Anti-Ataxin-1 wild-type, NeuroMab clone N65/37

Anti-ATF4, NeuroMab clone N360A/24

Anti-BAF53a, NeuroMab clone N336B/83

Anti-BAF53b, NeuroMab clone N332B/15

Anti-Bassoon, NeuroMab clone L124/59

Anti-BBS3/Arl6, NeuroMab clone N302/10

Anti-BBS5, NeuroMab clone N304B/115

Anti-BDNF, NeuroMab clone N450/53

Anti-Beta1-spectrin, NeuroMab clone N385/21

Anti-Beta4-spectrin, NeuroMab clone N393/2

Anti-Beta4-spectrin, NeuroMab clone N393/76

Anti-BKBeta2 potassium channel subunit, NeuroMab clone N53/32

Anti-BKBeta3a potassium channel subunit, NeuroMab clone N40B/18

Anti-BKBeta4 potassium channel, NeuroMab clone L18A/3

Anti-Botch1/Chac1, NeuroMab clone N116/14

Anti-Bral1, NeuroMab clone N364/10

Anti-Bral1, NeuroMab clone N364/42

Anti-Brevican, NeuroMab clone N294A/6

Anti-Brevican, NeuroMab clone N294A/10

Anti-CALB1/calbindin, NeuroMab clone L109/39

Anti-CALB1/calbindin, NeuroMab clone L109/57

Anti-CALB2/calretinin, NeuroMab clone L122/6

Anti-CALB2/calretinin, NeuroMab clone L122/68

Anti-CASK scaffolding protein, NeuroMab clone K56A/50

Anti-Caspr/paranodin/neurexin IV, NeuroMab clone K65/35

Anti-Caspr2/paranodin, NeuroMab clone K67/25

Anti-Cav1.2 calcium channel, NeuroMab clone L57/46

Anti-Cav1.2, NeuroMab clone N263/31

Anti-Cav1.3 calcium channel, NeuroMab clone L48A/9

Anti-Cav1.3 calcium channel, NeuroMab clone N38/8

Anti-Cav3.1 Ca2+ channel, NeuroMab clone N178A/9

Anti-Cav3.2 calcium channel, NeuroMab clone N55/10

Anti-Cav1 calcium channel, NeuroMab clone N7/18

Anti-Cav尾2 calcium channel subunit, NeuroMab clone N8b/1

Anti-Cav3 calcium channel, NeuroMab clone N473/36

Anti-Cav尾4 calcium channel, NeuroMab clone N10/7

Anti-Cdkl5, NeuroMab clone EA7

Anti-CDY1/2, NeuroMab clone N143/38

Anti-CDY1/2/L1/L2, NeuroMab clone N143/36

Anti-Celf4/Brunol4, NeuroMab clone N446/80

Anti-FOS, NeuroMab clone N486/32

Anti-FOS, NeuroMab clone N486/76

Anti-Clcn3, NeuroMab clone N258/5

Anti-Clcn4, NeuroMab clone N222/6

Anti-Clcn5, NeuroMab clone N406/47

Anti-CLN3, NeuroMab clone N380/87

Anti-CLN6, NeuroMab clone N400/24

Anti-CNGA1/3 cyclic nucleotide-gated channel, NeuroMab clone L36/12

Anti-Collybistin, NeuroMab clone L120/12

Anti-Collybistin, NeuroMab clone L120/30

Anti-Contactin/F3 scaffold protein, NeuroMab clone K73/20

Anti-Copper-transporting ATPase 1, NeuroMab clone L60/4

Anti-Copper-transporting ATPase 2 (Copper pump 2, Wilsons disease-associated protein, NeuroMab clone L62/29

Anti-Co-Rest/RCOR1 Transcriptional Co-Repressor, NeuroMab clone K72/8

Anti-DEPDC5, NeuroMab clone N463/52

Anti-Dicer, NeuroMab clone N167/7

Anti-DLX1 transcription factor, NeuroMab clone L43/40

Anti-DNAH1, NeuroMab clone N251/14

Anti-DNAH7, NeuroMab clone N250/21

Anti-DNAIC1, NeuroMab clone UNC 65.56.18.11

Anti-DNMT3L, NeuroMab clone N117/9

Anti-Doc2b, NeuroMab clone N150/21

Anti-Dopamine D2 receptor, NeuroMab clone N186/29

Anti-Dopamine D3 receptor, NeuroMab clone N331/19

Anti-EAAC1, NeuroMab clone N420/24

Anti-FGF11 (Fibroblast growth factor 11), NeuroMab clone N92/14

Anti-FGF12/FHF1, NeuroMab clone N94/17

Anti-FGF13 (Fibroblast growth factor 13), NeuroMab clone N91/27

Anti-FGF13B/FHF2B, NeuroMab clone N225A/10

Anti-FGF14/FHF4, NeuroMab clone N56/21

Anti-Fig4/Sac3, NeuroMab clone N202/7

Anti-Flrt3, NeuroMab clone N353/13

Anti-Foxi2, NeuroMab clone N349/96

Anti-Foxi3, NeuroMab clone N359/28

Anti-Frataxin, NeuroMab clone N191/7

Anti-GABA-A-R-Alpha1, NeuroMab clone N95/35

Anti-GABA-A-R-Alpha2, NeuroMab clone N399/19

Anti-GABA-A-R-Alpha4, NeuroMab clone N398A/34

Anti-GABA-A-R-Alpha5, NeuroMab clone N415/24

Anti-GABA-A-R-Alpha6, NeuroMab clone N229A/32

Anti-GABA-A-R-Beta1, NeuroMab clone N96/55

Anti-GABA-A-R-Beta2/3, NeuroMab clone 62-3G1

Anti-GABA-A-R-Beta3, NeuroMab clone N87/25

Anti-Delta GABA-A receptor, NeuroMab clone N151/3

Anti-GABA-A-R-Epsilon, NeuroMab clone N413/67

Anti-GABA-A-R-Gamma2L, NeuroMab clone N452/69

Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/73

Anti-GABA-A-R-Gamma2L/S, NeuroMab clone N452/30

Anti-GABA-A-R-Pi, NeuroMab clone N431/64

Anti- GABA-A-R-Theta, NeuroMab clone L123/109

Anti-GABABR1 GABA-B receptor, NeuroMab clone N93A/49

Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/2

Anti-GABABR2 GABA-B receptor, NeuroMab clone N81/37

Anti-GAD65/67, NeuroMab clone L127/12

Anti-GAD67, NeuroMab clone L127/8

Anti-Gamma-protocadherin-A3, NeuroMab clone N144/17

Anti-Gamma-protocadherin-B2, NeuroMab clone N148/30

Anti-Gamma-protocadherin-C3, NeuroMab clone N174B/27

Anti-Gamma-protocadherin-C4, NeuroMab clone N193A/13

Anti-Gephyrin, NeuroMab clone L106/83

Anti-Gephyrin, NeuroMab clone L106/93

Anti-Gephyrin, NeuroMab clone L106/4

Anti-GFAP, NeuroMab clone N206A/8

Anti-GFAP-R416WT, NeuroMab clone N206B/9

Anti-GFP (Green fluorescent protein), NeuroMab clone N86/8

Anti-GFP (Green fluorescent protein), NeuroMab clone N86/38

Anti-GFP (green fluorescent protein), NeuroMab clone N86/20

Anti-GFP (green fluorescent protein), NeuroMab clone N86/44

Anti-GIT1 scaffold protein, NeuroMab clone N39B/8

Anti-GIT2 scaffold protein, NeuroMab clone N83/48

Anti-GluA1/GluR1 glutamate receptor, NeuroMab clone N355/1

Anti-GluA2/GluR2 glutamate receptor, NeuroMab clone L21/32

Anti-KA2 kainate receptor, NeuroMab clone N279B/27

Anti-GluN1/NR1 glutamate receptor, NeuroMab clone N308/48

Anti-NR2A glutamate receptor, NeuroMab clone N327A/38

Anti-GluN2A/NR2A glutamate receptor, NeuroMab clone N327/95

Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/20

Anti-GluN2B/NR2B glutamate receptor, NeuroMab clone N59/36

Anti-GluN2C/NR2C, NeuroMab clone N422/18

Anti- GluN3A/NR3A, NeuroMab clone N416/40

Anti-Glycine receptor Alpha3, NeuroMab clone N424/45

Anti-Glycine receptor Alpha3L, NeuroMab clone N424/48

Anti-GRK6A/B, NeuroMab clone N142/28

Anti-Gs protein alpha subunit, NeuroMab clone N192/12

Anti-GST (Glutathione S-transferase), NeuroMab clone N100/13

Anti-Haspin/GSG2, NeuroMab clone N128A/2

Anti-HCN1 cyclic nucleotide-gated channel, NeuroMab clone N70/28

Anti-HCN2 cyclic nucleotide-gated channel, NeuroMab clone N71/37

Anti-HCN3 cyclic nucleotide-gated channel, NeuroMab clone N141/28

Anti-HCN4 cyclic nucleotide-gated channel, NeuroMab clone N114/10

Anti-Histone H2A.Z/V, NeuroMab clone N310/21

Anti-Histone H2A.Z acetyl-Lys4/7/11, NeuroMab clone N299/39

Anti-Histone H3.3, NeuroMab clone N158/28

Anti-Histone H3 acetyl-Lys56, NeuroMab clone N307/12

Anti-Histone H3-dimethyl-Arg8, NeuroMab clone N293/50

Anti-Histone H3 pThr11, NeuroMab clone N123/19

Anti-Histone H3 pThr11, NeuroMab clone N123/48

Anti-Histone H4-dimethyl-Arg3, NeuroMab clone N309A/21

Anti-Homer1L, NeuroMab clone L113/27

Anti-Homer1L, NeuroMab clone L113/13

Anti-Homer1, NeuroMab clone L113/130

Anti-ICK, NeuroMab clone N451/73

Anti-Iduna/RNF146, NeuroMab clone N201/35

Anti-INPP4b, NeuroMab clone N171/17

Anti IP3 receptor type 1 NeuroMab clone L24/18

Anti-IRSp53/BAIAP2, NeuroMab clone L117/1

Anti-JIP-2/IB-2, NeuroMab clone N135/37

Anti-JMJD2A, NeuroMab clone N154/32

Anti-KCC2 transporter, NeuroMab clone N1/66

Anti-KCC2 transporter, NeuroMab clone N1/12

Anti-KChIP1 potassium channel, NeuroMab clone K55/7

Anti-KChIP2 potassium channel subunit, NeuroMab clone K60/73

Anti-KChIP3 potassium channel, NeuroMab clone K66/38

Anti-KChIP4 K+ channel, NeuroMab clone N423/75

Anti-KCNT1/Slo2.2/Slack K+ channel, NeuroMab clone N3/26

Anti-KCNT2/Slo2.1/Slick sodium- and chloride-activated ATP sensitive potassium channel, NeuroMab clone N11/33

Anti-KCNU1/Slo3 pH-sensitive maxi potassium channel, NeuroMab clone N2/16

Anti-Keyhole limpet hemocyanin, NeuroMab clone N132A/12

Anti-Kir2.1 potassium channel, NeuroMab clone N112B/14

Anti-Kir2.2 potassium channel, NeuroMab clone N124B/38

Anti-Kir2.3 potassium channel, NeuroMab clone N25/35

Anti-Kir2.4 potassium channel, NeuroMab clone N465/11

Anti-Kir3.3 potassium channel, NeuroMab clone N455/15

Anti-Kir6.1 potassium channel, NeuroMab clone N366/60

Anti-Kir6.2 potassium channel, NeuroMab clone N363/71

Anti-Kirrel3 short and long, NeuroMab clone N321C/49

Anti-Kirrel3 short isoform 3, NeuroMab clone N320/48

Anti-Kv1.1 potassium channel subunit, NeuroMab clone K20/78

Anti-Kv1.1 potassium channel (external), NeuroMab clone K36/15

Anti-Kv1.2 potassium channel subunit, NeuroMab clone K14/16

Anti-Kv1.2 potassium channel subunit, NeuroMab clone L76/36

Anti-Kv1.3 potassium channel, NeuroMab clone L23/27

Anti-Kv1.4 potassium channel subunit, NeuroMab clone K13/31

Anti-Kv1.4 potassium channel (extracellular), NeuroMab clone L71/5

Anti-Kv1.5 potassium channel, NeuroMab clone K7/45

Anti-Kv1.6 potassium channel subunit, NeuroMab clone K19/36

Anti-Kv1.7 potassium channel, NeuroMab clone N471/27

Anti-Kv11.3 potassium channel, NeuroMab clone N447/24

Anti-Kv2.1 potassium channel subunit, NeuroMab clone L83/11

Anti-Kv2.1 potassium channel subunit, NeuroMab clone K89/34

Anti-Kv2.1 potassium channel subunit, NeuroMab clone L80/21

Anti-Kv2.1 potassium channel (external), NeuroMab clone K39/25

Anti-Kv2.2 potassium channel, NeuroMab clone K37/89

Anti-Kv2.2 potassium channel, NeuroMab clone N372C/51

Anti-Kv2.2 potassium channel, NeuroMab clone N372B/60

Anti-Kv2.2 potassium channel, NeuroMab clone N372B/1

Anti-Kv3.1b potassium channel, NeuroMab clone N16b/8

Anti-Kv3.2 potassium channel, NeuroMab clone N410/17

Anti-Kv3.3 potassium channel, NeuroMab clone N375/67

Anti-Kv3.4 potassium channel, NeuroMab clone N72/16

Anti-Kv4.2 potassium channel subunit, NeuroMab clone L28/4

Anti-Kv4.2 potassium channel (external), NeuroMab clone K57/1

Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/41

Anti-Kv4.3 potassium channel subunit, NeuroMab clone K75/30

Anti-Kv6.1 potassium channel, NeuroMab clone N474/27

Anti-Kv6.4 potassium channel, NeuroMab clone N458/10

Anti-KCNQ1 potassium channel, NeuroMab clone N37A/10

Anti-KCNQ2 potassium channel, NeuroMab clone N26A/23

Anti-KCNQ4 potassium channel, NeuroMab clone N43/6

Anti-Kv8.2 potassium channel, NeuroMab clone N448/88

Anti-Kv8.2 potassium channel, NeuroMab clone N448/50

Anti-Kv9.1 potassium channel, NeuroMab clone N461/19

Anti-Kv9.2 potassium channel, NeuroMab clone N460/19

Anti-Kvβ1.1 potassium channel subunit, NeuroMab clone K9/40

Anti-Kv1.2 potassium channel subunit, NeuroMab clone K47/42

Anti-Kv尾2 potassium channel, NeuroMab clone K17/70

Anti-Laforin, NeuroMab clone N84/37

Anti-LAR/PTPRF, NeuroMab clone N165/38

Anti-Lgi1, NeuroMab clone N283/7

Anti-Lhx6.1, NeuroMab clone N228A/16

Anti-LRP4 (cytoplasmic), NeuroMab clone N164/6

Anti-LRP4 (extracellular), NeuroMab clone N207/27

Anti-LRRK1, NeuroMab clone N341/37

Anti-LRRK1, NeuroMab clone N341/12

Anti-LRRK2/Dardarin, NeuroMab clone N241A/34

Anti-LRRK2/Dardarin, NeuroMab clone N231B/34

Anti-LRRK2/Dardarin, NeuroMab clone 8G10

Anti-LRRK2/Dardarin, NeuroMab clone N138/6

Anti-LRRK2/Dardarin-pSer910, NeuroMab clone 1D8

Anti-LRRTM2, NeuroMab clone N209C/35

Anti-LRRTM4, NeuroMab clone N205B/22

Anti-Mad3, NeuroMab clone N129A/6

Anti-Mad3, NeuroMab clone N129/15

Anti-Malin, NeuroMab clone N85/18

Anti-MBP (Maltose-binding protein), NeuroMab clone N128A/4

Anti-MAP3K12, NeuroMab clone N377/20

Anti-MAP3K12, NeuroMab clone N377/83

Anti-MECP2, NeuroMab clone N227/21

Anti-MESD, NeuroMab clone N88/12

Anti-MFF, NeuroMab clone N382/14

Anti-MFF (exon 1), NeuroMab clone N382/69

Anti-MGL, NeuroMab clone N90/20

Anti-mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/3

Anti- mGluR1/5 (group I) glutamate receptor, NeuroMab clone N75/33

Anti-Miro2, NeuroMab clone N384/63

Anti-MiRP4 potassium channel, NeuroMab clone N472/88

Anti-Mitofusin-1 (Mfn1), NeuroMab clone N111/24

Anti-Mitofusin-2 (Mfn2), NeuroMab clone N153/5

Anti-MMACHC, NeuroMab clone N230/21

Anti-MMP9 metalloproteinase, NeuroMab clone L51/82

Anti-MOG, NeuroMab clone L94/54

Anti-Mortalin/GRP75, NeuroMab clone N52A/42

Anti-MPP8, NeuroMab clone N119/44

Anti-NALCN, NeuroMab clone N185/7

Anti-Nav1.1 sodium channel, NeuroMab clone K74/71

Anti-Nav1.2 sodium channel, NeuroMab clone K69/3

Anti-Nav1.4 sodium channel, NeuroMab clone N255/38

Anti-Nav1.5 sodium channel, NeuroMab clone N397/19

Anti-Nav1.6 sodium channel, NeuroMab clone K87A/10

Anti-Nav1.7 sodium channel, NeuroMab clone N68/6

Anti-Nav1.8 sodium channel, NeuroMab clone N134/12

Anti-Navbeta1 Na+ channel, NeuroMab clone N405/74

Anti-Navbeta2 Na+ channel, NeuroMab clone N395/68

Anti-Navbeta3 Na+ channel, NeuroMab clone N396/29

Anti-Navbeta4 sodium channel, NeuroMab clone N168/6

Anti-NCKX4, NeuroMab clone N414/25

Anti-Neuregulin-CRD (Cysteine-rich domain, Type III), NeuroMab clone N126B/31

Anti-Neuregulin-HBD (Heparin-binding domain, Type I/II), NeuroMab clone N120A/9

Anti-Neurexin-1-Beta, NeuroMab clone N170A/1

Anti-Neurexin-1-Beta, NeuroMab clone N170A/26

Anti-Neuroligin-1, NeuroMab clone N97A/31

Anti-Neuroligin-2, NeuroMab clone L107/39

Anti-Neuroligin-3, NeuroMab clone N110/29

Anti-Neuroligin-4*, NeuroMab clone N98/47

Anti-Neuroligin-4*, NeuroMab clone N98/7

Anti-NGL-1 (Netrin-G1 ligand), NeuroMab clone N49A/21

Anti-NGL-2 (Netrin-G2 ligand) NeuroMab clone N50/36

Anti-NGL-3 (Netrin-G3 ligand), NeuroMab clone N51/6

Anti-NKCC1, NeuroMab clone N161/20

Anti-NOS1/nNOS, NeuroMab clone L121/25

Anti-NOS1/nNOS, NeuroMab clone L121/42

Anti-Notch1, NeuroMab clone N253/32

Anti-Npas4, NeuroMab clone N408/62

Anti-Npas4, NeuroMab clone N408/79

Anti-Neuropeptide Y, NeuroMab clone L115/13

Anti-NPY2R, NeuroMab clone L119/106

Anti-NrCAM, NeuroMab clone N343/26

Anti-NSD1, NeuroMab clone N312/10

Anti-NSD3, NeuroMab clone N348/82

Anti-OCRL/INPP5b, NeuroMab clone N166A/26

Anti-Olig1, NeuroMab clone N149/25

Anti-Pan-Ankyrin, NeuroMab clone N388A/60

Anti-Pancortin, NeuroMab clone K96/7

Anti-Pan-FHF-A, NeuroMab clone N235/22

Anti-Pan-Gamma-protocadherin-A, NeuroMab clone N144/32

Anti-Pan-Gamma-protocadherin, NeuroMab clone N159/5

Anti-Pan-GRK, NeuroMab clone N145/20

Anti-Pan-KChIP potassium channel, NeuroMab clone K55/82

Anti-Pan-Kv potassium channel, NeuroMab clone K40/17

Anti-Pan-Kvbeta potassium channel, NeuroMab clone K25/73

Anti-Pan-MAGUK scaffold proteins, NeuroMab clone K28/86

Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/40

Anti-Pan-Nav1 sodium channel, NeuroMab clone N419/78

Anti-pan-Neurofascin, NeuroMab clone L11A/41

Anti-Pan-Neurofascin (external), NeuroMab clone A12/18

Anti-Pannexin-2, NeuroMab clone N121A/1

Anti-Pannexin-2, NeuroMab clone N121A/31

Anti-Pan-PTPR, NeuroMab clone N165/43

Anti-Pan-QKI, NeuroMab clone N147/6

Anti-Pan-SAPAP, NeuroMab clone N127/31

Anti-pan-Shank (SH3 and multiple ankyrin repeat domains protein) scaffold protein, NeuroMab clone N23B/49

Anti-Pan-Synapsin, NeuroMab clone L125/129

Anti-Pan-Thyroid hormone receptor, NeuroMab clone N403/63

Anti-PARIS/ZNF746, NeuroMab clone N196/16

Anti-Parvalbumin, NeuroMab clone L114/3

Anti-Parvalbumin, NeuroMab clone L114/81

Anti-PEX6, NeuroMab clone N233/8

Anti-PEX7, NeuroMab clone N232/9

Anti-Phosphoserine-2-OEt, NeuroMab clone N257/25

Anti-Phosphoserine-2-OH, NeuroMab clone N259/48

Anti-Phosphoserine-2-OMe, NeuroMab clone N262/16

Anti-PhyH/PAHX, NeuroMab clone N210/5

Anti-PICK1 scaffold, NeuroMab clone L20/8

Anti-PINK1, NeuroMab clone N4/15

Anti-PINK1, NeuroMab clone N4/49

Anti-PINK1, NeuroMab clone N4/19

Anti-PINK1, NeuroMab clone N357/6

Anti-Proser1, NeuroMab clone N456/39

Anti-Prrt2, NeuroMab clone N485/22

Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/30

Anti-PSD-93/Chapsyn-110 scaffold protein, NeuroMab clone N18/28

Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/43

Anti-PSD-95 MAGUK scaffold protein, NeuroMab clone K28/74

Anti-QKI-5-NLS, NeuroMab clone N195A/16

Anti-QKI-6, NeuroMab clone N182/17

Anti-QKI-7, NeuroMab clone N183/15

Anti-QKI-7b, NeuroMab clone N194/11

Anti-RBM17/SPF45, NeuroMab clone N219/5

Anti-REEP, NeuroMab clone N326D/13

Anti-REEP1, NeuroMab clone N345/51

Anti-REEP1/2, NeuroMab clone N326D/29

Anti-REEP2, NeuroMab clone N326D/2

Anti-Rem2, NeuroMab clone N324/2

Anti-RGS14, NeuroMab clone N133/21

Anti-RGS14, NeuroMab clone N133/35

Anti-Rufy3, NeuroMab clone N483/84

Anti-Rufy3, NeuroMab clone N483/126

Anti-Rufy3, NeuroMab clone N483/26

Anti-S100A5, NeuroMab clone N176A/35

Anti-SALM2 synaptic adhesion-like molecule, NeuroMab clone N52B/27

Anti-SALM5/LRFN5, NeuroMab clone N140A/12

Anti-SAP102 MAGUK scaffold protein, NeuroMab clone N19/2

Anti-SAP97 scaffold protein, NeuroMab clone K64/15

Anti-SAPAP1, NeuroMab clone N238/29

Anti-SAPAP1, NeuroMab clone N238/30

Anti-SAPAP1/2, NeuroMab clone N238/31

Anti-SAPAP2, NeuroMab clone N459/84

Anti-SAPAP3, NeuroMab clone L126/93

Anti-SCG10/stathmin-2, NeuroMab clone L5/1

Anti-SH3GL1, NeuroMab clone K51/1

Anti-Shank1/ SPANK-1/Synamon/SSTRIP scaffold protein, NeuroMab clone N22/21

Anti-Shank1 and Shank3, NeuroMab clone N367/51

Anti-Shank2/ProSAP1/Spank-3/CortBP1 scaffold protein,NeuroMab clone N23B/6

Anti-Shank3 scaffold protein, NeuroMab clone N69/46

Anti-Shank3, NeuroMab clone N367/62

Anti-SK2 potassium channel, NeuroMab clone K78/29

Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/23

Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/48

Anti-Slo1/BKAlpha potassium channel, NeuroMab clone L6/60

Anti-Snapin (SNAP25 binding protein), NeuroMab clone L8/15

Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/37

Anti-SNAT1 Neurotransmitter Transporter NeuroMab clone N104/32

Anti-SST/Somatostatin, NeuroMab clone L111/118

Anti-S-tag, NeuroMab clone N56/9

Anti-Stonin-2, NeuroMab clone N346/9

Anti-SUR1, NeuroMab clone N289/16

Anti-SUR1 and SUR2B, NeuroMab clone N323A/31

Anti-SUR2A, NeuroMab clone N319A/14

Anti-SUR2B, NeuroMab clone N323B/20

Anti-SVOP, NeuroMab clone N356/9

Anti-SVOP, NeuroMab clone N356/23

Anti-Synapsin-III, NeuroMab clone L125/121

Anti-Synaptotagmin-10, NeuroMab clone N269/73

Anti-Synaptotagmin-12, NeuroMab clone N277/7

Anti-Synaptotagmin-3, NeuroMab clone N278/19

Anti-Synaptotagmin-5, NeuroMab clone N274/8

Anti-Synaptotagmin-6, NeuroMab clone N270/47

Anti-Synaptotagmin-7, NeuroMab clone N275/14

Anti-Synaptotagmin-9, NeuroMab clone N276A/15

Anti-SynCAM1 cell adhesion molecule, NeuroMab clone L45/30

Anti-SynCAM4, NeuroMab clone N244/5

Anti-SynDIG1/Tmem90b, NeuroMab clone L42/17

Anti-SynDIG3/Tmem91, NeuroMab clone N160/21

Anti-SynDIG4, NeuroMab clone L102/45

Anti-Tafazzin, NeuroMab clone N173B/13

Anti-TALK1 potassium channel, NeuroMab clone N466/14

Anti-TARPGamma2/Stargazin, NeuroMab clone N245/1

Anti-TARPGamma2/4/8, NeuroMab clone N245/36

Anti-TASK1 potassium channel, NeuroMab clone N374/48

Anti-Tauro-GM2, NeuroMab clone N175/9

Anti-THAP1, NeuroMab clone N325B/65

Anti-THIK-2 potassium channel, NeuroMab clone N468/37

Anti-Thioredoxin, NeuroMab clone N245/44

Anti-Thorase (Atad1), NeuroMab clone N125/10

Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/13

Anti-Thyroid hormone receptor beta1, NeuroMab clone N402/46

Anti- TRAAK potassium channel, NeuroMab clone N445/27

Anti-TRAK1, NeuroMab clone N389/9

Anti-TRAK2, NeuroMab clone N390/43

Anti-TRESK potassium channel, NeuroMab clone N467/1

Anti-TRIP8b (constant), NeuroMab clone N212/7

Anti-TRIP8b (constant), NeuroMab clone N212/17

Anti-TRIP8b (exon 1a/5 junction), NeuroMab clone N291C/22

Anti-TRIP8b (exon 1b), NeuroMab clone N212A/34

Anti-TRIP8b (exon 4), NeuroMab clone N212/3

Anti-TrpC1 calcium channel, NeuroMab clone 1F1

Anti-TrpC4 calcium channel, NeuroMab clone N77/15

Anti-TrpC5 calcium channel, NeuroMab clone N67/15

Anti-TrpC7 calcium channel, NeuroMab clone N64A/36

Anti-TrpM4, NeuroMab clone L88/86

Anti-TrpM6, NeuroMab clone N470/22

Anti-TrpM7 ion channel and Ser/Thr kinase, NeuroMab clone N74/25

Anti-TRPML3/Mucolipin-3, NeuroMab clone N268/19

Anti-TrpV1, NeuroMab clone N221/17

Anti-TrpV1, NeuroMab clone N221/12

Anti-TrpV3 cation channel, NeuroMab clone N15/4

Anti-TrpV3 cation channel, NeuroMab clone N15/39

Anti-TWIK-2 potassium channel, NeuroMab clone N469/28

Anti-Uncx, NeuroMab clone N155/9

Anti-VAChT vesicular acetylcholine transporter, NeuroMab clone N6/38

Anti-VAChT, NeuroMab clone N425/45

Anti-VAPA, NeuroMab clone N479/12

Anti-VAPA, NeuroMab clone N479/22

Anti-VAPA/B, NeuroMab clone N479/107

Anti-VDAC1, NeuroMab clone N152B/23

Anti-Versican, NeuroMab clone N351/23

Anti-Versican, NeuroMab clone N351/24

Anti-VGAT, NeuroMab clone L118/80

Anti-VGAT, NeuroMab clone L118/66

Anti-VGlut1, NeuroMab clone N28/9

Anti-VGlut2, NeuroMab clone N29/29

Anti-VGlut3, NeuroMab clone N34/34

Anti-VIP, NeuroMab clone L108/92

Anti-VMAT1, NeuroMab clone N440/21

Anti-VMAT1, NeuroMab clone N440/61

Anti-Slc18a2/VMAT2, NeuroMab clone N449/73

Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/21

Anti-Zebrafish VSP/TPTE, NeuroMab clone N432/63

Anti-WAVE1/SCAR, NeuroMab clone K91/36

Anti-WNK1, NeuroMab clone N391/68

Anti-WRN, NeuroMab clone N428/12

Zebrafish PSD Marker, NeuroMab clone N286/74

Anti-Zinedin/Striatin-4, NeuroMab clone K88/64

Anti-ZIP3, NeuroMab clone N476/9

Anti-ZNF423, NeuroMab clone N328B/37

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Neuromab"> Neuromab

...

阅读详情

艾美捷科技代理艾美捷科技代理Larodan品牌脂质产品。

Larodan公司设施位于瑞典斯德哥尔摩的卡罗林斯卡学院校园内。Larodan提供多种脂肪酸、甘油酸、磷脂及其他脂类相关物质。Larodan 生产高纯度脂质，用作标准品、试剂和原料，其化合物目录涵盖了大多数类别的脂质——从脂肪酸和氧脂素到甘油酯和磷脂。此外，Larodan公司还提供脂质和类脂化合物的定制合成服务。涉及生物科学研究、药物科学、食品油脂化学和营养科学等多个领域。产品范围主要包括：

（1）脂肪酸（Fatty Acids）：提供多种饱和脂肪酸、单不饱和脂肪酸和多不饱和脂肪酸。

（2）氧脂素（Oxylipins）：包括前列腺素、白三烯、羟基脂肪酸等氧化脂质。

（3）甘油酯（Glycerides）：提供单酰基甘油、二酰基甘油和三酰基甘油（甘油三酯）。

（4）磷脂（Phospholipids）：包括磷脂酰胆碱（PC）、磷脂酰乙醇胺（PE）、磷脂酰丝氨酸（PS）等。

（5）鞘脂（Sphingolipids）：提供鞘氨醇、神经酰胺和鞘磷脂等。

（6）胆固醇及其衍生物（Cholesterol and Derivatives）：提供胆固醇、胆固醇酯和氧化胆固醇等。

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Larodan品牌脂质产品"> 艾美捷科技代理Larodan品牌脂质产品

...

阅读详情

Rocky Mountain Diagnostics公司成立于2001年，主要产品涉及生物胺类、内分泌学、食品安全、研究分析/研究高敏感度、唾液试验、酶联免疫试剂盒等。

RMD was established in 2001 with a vision of marketing high quality in vitro diagnostics in the US. This vision, combined with the more than 40 years of experience of our partner organizations and exclusive dedication to immunodiagnostics, has made RMD together with its parent company the worldwide leaders in biogenic amine assays.

Rocky Mountain Diagnostics公司主要产品：

Biogenic Amines

Endocrinology

Food Safety - Featuring Histasure

Research Assays / Research High-Sensitive

Salivary Assays

Elisa Kit

更多详情请联系

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

" data-original="http://lifesensors.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Rocky Mountain Diagnostics"> Rocky Mountain Diagnostics

...

阅读详情

806 807 808 809 810 811 812 813 814 815

城市分站

友情链接 invivoCrown IV0100替换BioXCell BE0146 invivoCrown IV0115替换BioXCell BE0060 invivoCrown IV0117替换BioXCell BE0223 invivoCrown IV0121替换BioXCell BE0001-1 invivoCrown IV0111替换BioXCell BE0036 invivoCrown IV0111替换BioXCell BE0036 invivoCrown IV0106替换BioXCell BE0090 invivoCrown IV0103替换BioXCell BE0075-1 invivoCrown IV0110替换BioXCell BE0058 invivoCrown IV0109替换BioXCell BE0164

联系我们

地址：武汉市洪山区光谷大道35号光谷总部国际时代二期1栋1301

电话：18372041646

传真：18372041646

邮箱：sales@amyjet.com

0.2825